TP53 and leukemia: To determine whether p53 levels in MSCs contribute to the response to MDM2i, we established a traceable syngeneic leukemia model in Osx-Cre;mTmG and Osx-Cre;mTmG;Trp53fl/fl mice and analyzed their survival.